Clinical trial
A REAl-life Study on Short-term Dual Antiplatelet Treatment in Patients With Ischemic Stroke or Transient Ischemic Attack
NCT05476081 is registered in ClinicalTrials.gov with University of L'Aquila as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A REAl-life Study on Short-term Dual Antiplatelet Treatment in Patients With Ischemic Stroke or Transient Ischemic Attack
- Lead sponsor
- University of L'Aquila
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 3, 2021
- Completion date
- May 3, 2023
- Enrollment
- 2,239 (actual)
- Sites
- 127
Conditions
As the registry lists them; a condition with its own page is linked.
ischemic stroke, tia